Year archive

POOLBEG PHARMA PLC — 2023 filings

All 30 regulatory filings released by POOLBEG PHARMA PLC (POLB) in 2023, sourced directly from the official regulator.

30 Filings

2023 Period

2023 filings (30)

Filing	Released	Lang
RSV AI Drug Candidate Analysis Update Regulatory Filings	2023-12-20	English
POLB 001 Data Presented at ASH Regulatory Filings	2023-12-11	English
Directorate Change Board/Management Information	2023-11-30	English
Immunomodulator II patent granted in Japan Regulatory Filings	2023-11-21	English
POLB 001 LPS Trial Data to be Presented at IUIS Regulatory Filings	2023-11-16	English
Former Amryt Pharma Leadership Team join Poolbeg Board/Management Information	2023-11-09	English
POLB001 Data to be Presented at ASH Annual Meeting Regulatory Filings	2023-11-03	English
POLB 001 Oncology Programme Update Meeting Report Publication Announcement	2023-11-01	English
SAB Endorses Influenza Drug Targets Environmental & Social Information	2023-10-26	English
Poolbeg Partners with a Nasdaq-Listed Biopharma Regulatory Filings	2023-10-17	English
Favourable Conclusion of Patent Opposition Legal Proceedings Report	2023-09-29	English
Immunomodulator I Patent Portfolio Strengthened Regulatory Filings	2023-09-20	English
Immunomodulator I Patent Opposition Withdrawal Regulatory Filings	2023-09-19	English
Interim results for the six months to 30 June 2023 Interim / Quarterly Report H1 2023	2023-09-13	English
AI led programme identifies influenza drug targets Regulatory Filings	2023-06-29	English
Oral Vaccine Programme Moves Forward Regulatory Filings	2023-06-22	English
Board Appointment Board/Management Information	2023-05-24	English
Results of Annual General Meeting AGM Information	2023-05-11	English
Annual Report & AGM Notice Report Publication Announcement	2023-04-12	English
Results for the year ended 31 December 2022 Report Publication Announcement FY 2022	2023-03-30	English
Notification of Major Holdings Major Shareholding Notification	2023-03-10	English
Notification of Major Holdings Major Shareholding Notification	2023-03-09	English
POLB 001 patent portfolio strengthened Share Issue/Capital Change	2023-03-08	English
Second Price Monitoring Extn Regulatory Filings	2023-03-02	English
Price Monitoring Extension Regulatory Filings	2023-03-02	English
Positive Results POLB001 LPS Human Challenge Trial Earnings Release Q1 2023	2023-03-02	English
Strategic expansion of POLB 001 into oncology Regulatory Filings	2023-01-16	English
Second Price Monitoring Extn Regulatory Filings	2023-01-09	English
Price Monitoring Extension Regulatory Filings	2023-01-09	English
Positive Initial Data Analysis in POLB 001 Trial Earnings Release Q2 2023	2023-01-09	English